Sander I. van Leuven

2.5k total citations
45 papers, 1.8k citations indexed

About

Sander I. van Leuven is a scholar working on Immunology, Rheumatology and Surgery. According to data from OpenAlex, Sander I. van Leuven has authored 45 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 13 papers in Rheumatology and 12 papers in Surgery. Recurrent topics in Sander I. van Leuven's work include Atherosclerosis and Cardiovascular Diseases (21 papers), Lipoproteins and Cardiovascular Health (10 papers) and Systemic Lupus Erythematosus Research (10 papers). Sander I. van Leuven is often cited by papers focused on Atherosclerosis and Cardiovascular Diseases (21 papers), Lipoproteins and Cardiovascular Health (10 papers) and Systemic Lupus Erythematosus Research (10 papers). Sander I. van Leuven collaborates with scholars based in Netherlands, United States and United Kingdom. Sander I. van Leuven's co-authors include John J.P. Kastelein, Erik S.G. Stroes, Michiel L. Bots, Jan Albert Kuivenhoven, Paul P. Tak, Charles L. Shear, Ward A. Riley, James H. Revkin, William Duggan and Philip J. Barter and has published in prestigious journals such as New England Journal of Medicine, Circulation and PLoS ONE.

In The Last Decade

Sander I. van Leuven

45 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sander I. van Leuven Netherlands 20 683 458 449 448 394 45 1.8k
Ahmed Hasan United States 20 490 0.7× 553 1.2× 686 1.5× 270 0.6× 139 0.4× 46 2.5k
Domenico Ferro Italy 33 779 1.1× 451 1.0× 557 1.2× 265 0.6× 442 1.1× 79 3.1k
Kashif Jafri United States 10 968 1.4× 252 0.6× 374 0.8× 862 1.9× 254 0.6× 13 1.9k
Martin Ellis Israel 28 407 0.6× 188 0.4× 279 0.6× 280 0.6× 140 0.4× 141 2.4k
Peter Santer Austria 18 789 1.2× 387 0.8× 477 1.1× 377 0.8× 216 0.5× 26 2.5k
Inés Rama Spain 18 475 0.7× 357 0.8× 466 1.0× 162 0.4× 110 0.3× 37 2.5k
Roland Klingenberg Switzerland 27 918 1.3× 730 1.6× 712 1.6× 198 0.4× 148 0.4× 86 2.3k
Marina Camera Italy 33 1.1k 1.7× 695 1.5× 1.1k 2.4× 243 0.5× 449 1.1× 108 3.9k
Hyunsook Chin United States 20 526 0.8× 214 0.5× 270 0.6× 272 0.6× 269 0.7× 54 1.9k
Aaron W. Aday United States 18 939 1.4× 243 0.5× 446 1.0× 328 0.7× 64 0.2× 54 1.7k

Countries citing papers authored by Sander I. van Leuven

Since Specialization
Citations

This map shows the geographic impact of Sander I. van Leuven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sander I. van Leuven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sander I. van Leuven more than expected).

Fields of papers citing papers by Sander I. van Leuven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sander I. van Leuven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sander I. van Leuven. The network helps show where Sander I. van Leuven may publish in the future.

Co-authorship network of co-authors of Sander I. van Leuven

This figure shows the co-authorship network connecting the top 25 collaborators of Sander I. van Leuven. A scholar is included among the top collaborators of Sander I. van Leuven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sander I. van Leuven. Sander I. van Leuven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leuven, Sander I. van, Lenny van Bon, Robin Nijveldt, & Amy S. Major. (2025). Atherosclerotic cardiovascular disease in systemic lupus erythematosus: from preclinical lupus to atherosclerotic plaque erosion. Rheumatology Advances in Practice. 9(2). rkaf048–rkaf048. 1 indexed citations
2.
Vos, Jacqueline L, Miranda Snoeren, Arie P.J. van Dijk, et al.. (2024). Peripheral microvascular function is linked to cardiac involvement on cardiovascular magnetic resonance in systemic sclerosis–related pulmonary arterial hypertension. European Heart Journal - Cardiovascular Imaging. 25(5). 708–717. 4 indexed citations
3.
Caam, A. van, Jacqueline L Vos, E.L. Vitters, et al.. (2024). Systemic sclerosis-associated pulmonary arterial hypertension is characterized by a distinct peripheral T helper cell profile. Lara D. Veeken. 63(9). 2525–2534. 1 indexed citations
4.
Leuven, Sander I. van & Amy S. Major. (2023). Accelerated atherosclerosis in systemic lupus erythematosus: don’t forget the devil we know!. Lara D. Veeken. 63(1). 3–5. 1 indexed citations
5.
Leuven, Sander I. van. (2023). Are Patients With Systemic Sclerosis Subject to an Increased Risk of Developing Superficial Erosion of Atherosclerotic Plaques?. The Journal of Rheumatology. 50(12). 1638–1639. 1 indexed citations
6.
Ende, Cornelia HM van den, Hanneke Knaapen, Arie P.J. van Dijk, et al.. (2023). Nailfold capillaroscopy and candidate-biomarker levels in systemic sclerosis-associated pulmonary hypertension: A cross-sectional study. Journal of Scleroderma and Related Disorders. 8(3). 221–230. 3 indexed citations
7.
Moor, Catharina C., Sander I. van Leuven, Marlies Wijsenbeek, & Madelon C Vonk. (2020). Feasibility of online home spirometry in systemic sclerosis–associated interstitial lung disease: a pilot study. Lara D. Veeken. 60(5). 2467–2471. 24 indexed citations
8.
Subesinghe, Sujith, et al.. (2017). Cocaine and ANCA associated vasculitis-like syndromes – A case series. Autoimmunity Reviews. 17(1). 73–77. 25 indexed citations
9.
Moens, Sophie J. Bernelot, Sander I. van Leuven, Kang H. Zheng, et al.. (2016). Impact of the B Cell Growth Factor APRIL on the Qualitative and Immunological Characteristics of Atherosclerotic Plaques. PLoS ONE. 11(11). e0164690–e0164690. 10 indexed citations
10.
Leuven, Sander I. van, Yanice Mendez-Fernandez, Erik S.G. Stroes, Paul P. Tak, & Amy S. Major. (2010). Statin therapy in lupus-mediated atherogenesis: two birds with one stone?. Annals of the Rheumatic Diseases. 70(2). 245–248. 26 indexed citations
11.
Leuven, Sander I. van, Rakesh S. Birjmohun, Remco Franssen, et al.. (2008). ApoAI‐phosphatidylcholine infusion neutralizes the atherothrombotic effects of C‐reactive protein in humans. Journal of Thrombosis and Haemostasis. 7(2). 347–354. 15 indexed citations
12.
Leuven, Sander I. van, Erik S.G. Stroes, & John J.P. Kastelein. (2008). High-density lipoprotein: A fall from grace?. Annals of Medicine. 40(8). 584–593. 8 indexed citations
13.
Leuven, Sander I. van, Johannes H.M. Levels, Pieter Stokkers, et al.. (2007). Enhanced atherogenesis and altered high density lipoprotein in patients with Crohn's disease. Journal of Lipid Research. 48(12). 2640–2646. 80 indexed citations
14.
Birjmohun, Rakesh S., Radjesh J. Bisoendial, Sander I. van Leuven, et al.. (2007). A single bolus infusion of C-reactive protein increases gluconeogenesis and plasma glucose concentration in humans. Metabolism. 56(11). 1576–1582. 16 indexed citations
15.
Kastelein, John J.P., et al.. (2007). Effects of Torcetrapid on Carotid Atherosclerosis in Familial Hypercholesterolemia. Journal of Vascular Surgery. 46(2). 394–394. 1 indexed citations
16.
Leuven, Sander I. van, S J van Deventer, John J.P. Kastelein, et al.. (2006). Abstract 1497: Enhanced atherogenesis and altered High Density Lipoprotein in patients with Crohn's Disease. Circulation. 114. 1 indexed citations
17.
Leuven, Sander I. van, Rakesh S. Birjmohun, J.H.M. Levels, et al.. (2006). Tu-W16:5 High density lipoprotein abolishes atherothrombotic effects of C-reactive protein in humans. Atherosclerosis Supplements. 7(3). 153–153. 1 indexed citations
18.
Leuven, Sander I. van, et al.. (2006). Mycophenolate mofetil as an immunomodulatory silver bullet in atherogenesis?. Lupus. 15(11_suppl). 11–17. 1 indexed citations
19.
Leuven, Sander I. van, et al.. (2006). The dyslipidemia of chronic renal disease: effects of statin therapy. Current Opinion in Lipidology. 17(6). 659–666. 9 indexed citations
20.
Leuven, Sander I. van, et al.. (2005). Mycophenolate mofetil (MMF): Firing at the atherosclerotic plaque from different angles?. Cardiovascular Research. 69(2). 341–347. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmed Hasan Breakdown of academic impact, for papers by Domenico Ferro Breakdown of academic impact, for papers by Kashif Jafri Breakdown of academic impact, for papers by Martin Ellis Breakdown of academic impact, for papers by Peter Santer Breakdown of academic impact, for papers by Inés Rama Breakdown of academic impact, for papers by Roland Klingenberg Breakdown of academic impact, for papers by Marina Camera Breakdown of academic impact, for papers by Hyunsook Chin Breakdown of academic impact, for papers by Aaron W. Aday
Rankless by CCL
2026